Our study detected the first innovative combination of DRP1 and OPA1 to predict cognitive impairment in diabetes mellitus, which showed important clinical significance for better understanding the pathogenesis of cognitive impairment in diabetes mellitus. This evidence concerns the gene OPA1 and diabetes mellitus.